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Table 1
Association of progression in joint space narrowing (JSN) or joint space width (JSW)
with Power Doppler signal and synovitis on ultrasound in 1336 joints in both hands













Adj. OR 95% CI)
JSW
Synovitis
Grade 0 58 1179 1 127 1110 1
Grade 1 8 44 4.5 (1.7;12.1) 16 36 3.7 (1.7;8.2)
Grade 2 6 28 5.0 (1.9;13) 8 26 2.7 (1.2;6.3)
Grade 3 4 8 10.6 (3.2;35) 4 8 4.5 (1.0;19.4)
Power Doppler
Grade 0 58 1189 1 134 1113 1
Grade 1 10 54 3.8 (1.8;7.7) 12 52 1.6 (0.96; 2.8)
Grade 2þ3 8 17 10.6 (4.7;23.7) 9 16 5.7 (2.1; 15.6)
Abbreviations: Prog ¼ progression, OR ¼ Odds Ratio, CI ¼ conﬁdence interval.
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THE ANALYSIS OF ECONOMIC BURDEN FOR THE TREATMENT OF
OSTEOARTHRITIS IN CHINA: ANALYSIS OF 67382 OUT-PATIENTS
FROM PEKING UNIVERSITY PEOPLE'S HOSPITAL
H. Zhang, Z. Li, L. Jiang, X. Dong, Q. Zhong, J. Lin. Peking Univ. People's
Hosp., Beijing, China
Purpose: With a high prevalence of osteoarthritis (OA) in the old
population, the outpatient treatment of OA may bring economic bur-
den. Until now, there is no report about the economic burden of OA in
China. In this study, we aim to analysis the economic burden of OA in
China.
Methods: The study enrolled all out-patients prescriptions for the
treatment of osteoarthritis in Peking University People's Hospital in
2012. Statistical method was applied to analyze the average cost of each
prescription for out-patients and the cost structure.
Results: A total of 67382 prescriptions involving 25410 osteoarthritis
out- patients were enrolled in this study. The incidence of OA-related
visits to the hospital was 2.6 times per year per person. The direct cost
of out-patient service for osteoarthritis in 2012 in all in this hospital was
283.59 million Yuan, in average each visit to the hospital may spend
420.9 Yuan. In all kind of medicine, the cost of traditional Chinese
medicine was the highest (156.2 Yuan per prescription, 37.1%), followed
by glucosamine (139.0 Yuan per prescription, 33.0%), anti-osteoporosis
drugs (77.9 Yuan per prescription, 18.5%), intra-articular medicine (20.7
Yuan per prescription, 4.9%), NSAIDs (19.6 Yuan per prescription, 4.7%),
topical NSAIDs and capsaicin (3.8 Yuan per prescription, 0.9%), weak
opioids (3.3 Yuan per prescription, 0.8%), acetaminophen (0.4 Yuan per
prescription, 0.1%).
Conclusions: Among all the medicine for the treatment of OA, the cost
of traditional Chinese medicine and glucosamine is much more higher
than others, which is based on no clear guidelines.
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SENSITIVITY TO CHANGE AND VALIDITY OF SEMI-AUTOMATED JOINT
SPACE WIDTH MEASUREMENTS IN HAND OSTEOARTHRITIS: A
FOLLOW-UP STUDY
W. Damman, M.C. Kortekaas, B.C. Stoel, R. van 't Klooster,
F.R. Rosendaal, M. Kloppenburg. Leiden Univ. Med. Ctr. (LUMC), Leiden,
Netherlands
Purpose: Cartilage loss, represented by joint space on radiographs, is an
important outcome measure of the disease course in hand osteo-
arthritis (OA). Joint Space Width (JSW) in mm has been assessed
quantitatively and semi-automated in a valid and reliable way in cross-
sectional studies. This seems more feasible than semi-quantitative
scoring of joint space narrowing (JSN) and could therefore be useful in
clinical trials. However, it is not knownwhether the JSWmethod is also
valid and sensitive-to-change over time.
Methods: We used data of 56 participants (mean age 62 yrs, 86%
women, mean BMI 28 kg/m2, median number of tender joints 5 (range
0-19)) of the ECHO study, set up to show whether inﬂammatory
ultrasound features are associated with radiographic progression. Pri-
mary hand OA patients were included between 2008-2010. Physical
examination and ultrasound were performed on both hands at baseline.
Digital hand radiographs (dorsal-volar views) were taken at baseline and
after two years and scored according to the OARSI JSN and the Ver-
bruggen-Veys anatomical phase scoring. JSWwasmeasured inbothhands
in 2nd to 5th DIP, PIP and MCP joints (n¼24) with a semi-automatic
quantiﬁcation method (van 't Klooster Osteoarthritis Cartilage 2008; 16:
18-25. Openly available through www.lkeb.nl (software downloads)).
JSW change per joint group (DIP, PIP or MCP) was quantiﬁed using
linear mixed models adjusting for age, sex and BMI. Sensitivity-to-
change in JSW was evaluated by calculating Standardized Response
Means (SRMs) per joint group. Progression on joint level was deﬁned as
a change more than the Smallest Detectable Difference (SDD) in JSWmeasurements and as one point increase for JSN scoring. SDDs were
calculated by measuring two radiographs from 21 hand OA patients
acquired within a 6-months interval, assuming no progression over
such short time.
We evaluated validity by cross-tabulation of the number of progressive
joints according to the two methods (i.e. JSW and JSN) and compared
the associations of inﬂammatory variables with progression. We
hypothesized that these inﬂammatory variables, being Power Doppler
Signal and synovitis assessed with ultrasonography at baseline, are
associated with a decrease in joint space. Generalized Estimating
Equations were used to do this analysis, adjusting for age, sex and BMI.
In sensitivity analyses investigating progression in joints at risk for
progression, joints with a JSN baseline score of 0 or 3 were omitted. In
another sensitivity analysis joints at risk for widening, i.e. with erosive
disease, were omitted.
Results: 1336 joints were investigated. The mean JSW on baseline was
0.61 mm (SD 0.27) in DIP joints, 0.79 mm (0.26) in PIP joints and 1.33
mm (0.29) in MCP joints. In all joints groups a statistically signiﬁcant
decrease in JSW, ranging from -0.021 to -0.027 mm, was seen after 2.6
years. In joints with a baseline JSN score of 1 and 2 this decrease was
particularly clear.
SRMs ranged from 0.168 to 0.211. Sensitivity analyses investigating
joints at risk for progression improved the SRMs, ranging from 0.285 to
0.561. Omitting erosive joints did not improve the SRMs.
The SDDs in JSW were 0.116 mm, 0.135 mm and 0.202 mm for the
DIP, PIP and MCP joints, respectively. Based on the SDD 155 joints
(11.6%) progressed according to JSW measurements, whereas 76
(5.7%) progressed according to JSN scoring. Only half of these 76
progressed joints was also classiﬁed as progressed according to the
JSW method, elucidating discordant results. Widening was seen in
64 (4.8%) and 8 (0.6%) joints in JSW and JSN measurements,
respectively.
Progression deﬁned following both methods was associated with the
inﬂammatory ultrasound variables, depicted in table 1, showing a better
association for JSN progression. Sensitivity analyses did not show better
results.
Conclusions: Semi-automated JSW measurement showed statistically
signiﬁcant, though very small, mean changes over 2.6 years. SRMs were
low, although increased when only joints with JSN baseline score of 1 or
2 were taken into account. Many joints (11.6%) passed the threshold for
progression, but with also many joints (4.8%) that ‘widen’, suggesting
that there is considerable bias. When evaluating validity JSW performed
worse in comparison with JSN, which was not solved by omitting joints
with JSN baseline score 0 or 3.
The results suggest that progression measured with semi-automated
JSW measurements performs less than progression assessed by semi-
quantitative JSN scoring and is therefore currently not useful in trials.
